PHARMAC is pleased to announce the approval of an agreement with Vifor Pharma Pty Ltd to list Ferinject in Section H of the Pharmaceutical Schedule from 1 August 2014.

This proposal was the subject of a consultation letter dated 16 May 2014, available on PHARMAC’s website.

Following consideration of consultation feedback, a restriction has been added to the Section H listing.

For more details, go to: http://www.pharmac.health.nz/news/notification-2014-07-29-ferric-carboxymaltose/